[Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
We report two cases of congenital toxoplasmosis following maternal primary infection occurring late during pregnancy. These congenital infections are often asymptomatic at birth and can be recognized only by an appropriate serological screening program performed in mothers after delivery.
Wirden
M
M
Unité de Parasitologie, Centre Hospitalo-Universitaire de Bicêtre, Kremlin-Bicêtre.
Botterel
F
F
Romand
S
S
Ithier
G
G
Bourée
P
P
D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D013411:Sulfadiazine; D011739:Pyrimethamine
Intérêt du dépistage en post-partum de la toxoplasmose congénitale après primo-infection maternelle en fin de grossesse.